📰 Sponsored Trial News
Sponsored Trial News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sponsored Trial. Real-time updates on events, politics, business and more.
December 6, 2022
CARSON CITY, Nev., Dec. 06, 2022 -- BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced... | December 6, 2022
September 6, 2022
- Investigator Sponsored Trial sites in Australia include St. Vincents Hospital, Sydney, Alfred Health, Melbourne, and the Royal Victorian Eye and Ear...
April 19, 2021
. The rESPECT IST (NCT04292743) is a single arm, dose escalating Phase 1 clinical trial to evaluate the safety of eryaspase in combination with modified FOLFIRINOX. The trial is conducted by Dr Marcus Noel, Associate Professor of Medicine at Georgetown University, Washington DC, USA, and will enroll approximately 18 patients who have received no prior chemotherapy for the treatment of locally advanced or metastatic pancreatic cancer. FOLFIRINOX is one of the most commonly utilized first-line ch...
April 19, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ERYTECH Announces Completion of First Cohort in a Phase 1 Investigator Sponsored Trial of ... Erytech Pharma S.A.April 19, 2021 GMT ERYTECH Announces Completion of First Cohort in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer No dose-limiting toxicity reported in the first dose cohort Encouraging clinical activity observed in first patients Trial will be escalat...